A Double-Blind, Placebo-Controlled Trial of Acetyl-L ...juvenon.com/pdfs/juvenon_memory.pdf · A...

Preview:

Click to see full reader

Citation preview

A Double-Blind, Placebo-Controlled Trial of Acetyl-L-Carnitine and Alpha-Lipoic Acidfor Age-Associated Memory Impairment

Rolf J. Martin, Ph.D.1, Bruce N. Ames,Ph.D.2 and Benjamin V. Treadwell, Ph.D.3

1MMT Corporation, Sherman, CT. 2Children’s Hospital Oakland Re-search Institute, Oakland, CA. 3Juvenon, Inc., Incline Village, NV.

H

Recommended

A Phase 3 Randomized, Double-Blind, Placebo-Controlled
Documents
Results from a randomized, double-blind, placebo-controlled
Documents
A PHASE II RANDOMIZED DOUBLE-BLIND PLACEBO …
Documents
A randomized double-blind placebo-controlled phase IIB ...cancerpreventionresearch.aacrjournals.org/content/canprevres/early/... · A randomized double-blind placebo-controlled phase
Documents
A Phase III Randomized, Double-blind, Placebo-controlled
Documents
A Randomized, Double-Blind, Placebo-Controlled, Phase 3
Documents
Double-blind, placebo-controlled, dose-ranging trial of ...This was a double-blind, placebo-controlled study of the acute efficacy of IV ketamine or placebo added to ongoing antidepressant
Documents
A Randomised, Double-blind Placebo-controlled Phase IIa
Documents
Open-label versus double-blind placebo treatment in
Documents
VERSION: 1.0 A Randomized, Double-blind, Placebo
Documents
double blind, placebo-controlled study geriatric patients
Documents
Multicenter double-blind, randomized, placebo …Multicenter double-blind, randomized, placebo-controlled trial of IDEC-C2B8 for the treatment of childhood-onset complicated nephrotic
Documents
A randomized, double-blind, placebo-controlled multicenter
Documents
Double-Blind, Placebo-Controlled, Randomized Study
Documents
A Prospective, Double Blind, Randomized, Placebo
Documents
Randomized, Double-Blind, Placebo-Controlled, Phase 1
Documents
A Dbuble-Blind,. Randomized, Placebo-Controlled Trial
Documents
A Phase 3 Multicenter, Randomized, Double-blind, Placebo
Documents
A Prospective, Randomized Double-Blind, Placebo-Controlled
Documents
Phase III Randomized, Double Blind, Placebo- Controlled
Documents